International Assets Investment Management’s Charles River Laboratories CRL Stock Holding History

International Assets Investment Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-42,546	Closed	-$216	–	1041
2024 Q3	$216	Buy	+42,546	New	+$8.84M	﹤0.01%	1524
2022 Q1	–	Sell	-544	Closed	-$205K	–	504
2021 Q4	$205K	Buy	+544	New	+$211K	0.04%	458
2021 Q2	–	Sell	-80	Closed	-$20K	–	783
2021 Q1	$20K	Hold	80	–	–	﹤0.01%	1296
2020 Q4	$20K	Buy	+80	New	+$19.1K	﹤0.01%	1159

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return

Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return

International Assets Investment Management's CRL Position: Q4 2024 in Review

International Assets Investment Management sold out of Charles River Laboratories (CRL) in Q4 2024, closing a stake of 42,546 shares — an estimated $216 sold.

International Assets Investment Management first reported a position in CRL in Q4 2020 and held it in 4 quarters. The position peaked at $205K in Q4 2021. 636 funds tracked by Wall St. Rank hold CRL as of Q4 2024.

International Assets Investment Management reported no remaining Charles River Laboratories position as of Q4 2024 after selling out during the quarter.
International Assets Investment Management sold 42,546 Charles River Laboratories shares in Q4 2024, an estimated $216.
International Assets Investment Management first reported a position in Charles River Laboratories in Q4 2020 and held it in 4 quarters.
International Assets Investment Management's Charles River Laboratories position peaked at $205K in Q4 2021.
636 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2024.

Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.